Drug profile · INN
tbo-filgrastim
GRANIX
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
tbo-filgrastim (GRANIX) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN tbo-filgrastim
Brand GRANIX
Route INJECTION
Formulation INJECTABLE
Frequently asked questions
What is tbo-filgrastim?
tbo-filgrastim (GRANIX) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for tbo-filgrastim?
GRANIX is a marketed brand name for tbo-filgrastim. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of tbo-filgrastim?
tbo-filgrastim has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.